Close Menu

NEW YORK – Rosa Biotech said Thursday that it has raised £760,000 ($984,000) from angel investors to commercialize an artificial intelligence-based biosensing technology that mimics mammals’ sense of smell with a potential application for medical diagnostics and pharmaceuticals.

University of Bristol, UK-spinout Rosa said that it will use the funding to grow its team, build out an automated platform, and demonstrate the utility of its technology to address challenges in new sectors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.